Endeavor Orthopaedics is an IP-protected platform technology company focused on the treatment of avulsion fractures. Endeavor was founded by an experienced Orthopedic Surgeon with the mission to address the unsolved clinical problems associated with the treatment of these extremely complicated fractures. The Company’s first commercial product is the Summit Patella Plating System, with future products planned for the olecranon, greater tuberosity, and greater trochanter. Avulsion fractures are believed to represent just over 9% of the 6.5 million fractures to occur annually in the U.S. and represents a greater than $2B market. The Company’s first of four U.S. patents were issued in October of 2013.